Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Fujioka

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Life Science Alliance|September 30, 2024
Metabolic resistance of Aβ3pE-42, a target epitope of the anti-Alzheimer therapeutic antibody, donanemabNobuhisa Iwata, Satoshi Tsubuki, Misaki Sekiguchi, et al.
Acta Neuropathologica Communications|July 5, 2022
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosisRicheng Jiang, Una Smailovic, Hazal Haytural, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Life Science Alliance|September 30, 2024
Metabolic resistance of Aβ3pE-42, a target epitope of the anti-Alzheimer therapeutic antibody, donanemabNobuhisa Iwata, Satoshi Tsubuki, Misaki Sekiguchi, et al.
Acta Neuropathologica Communications|July 5, 2022
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosisRicheng Jiang, Una Smailovic, Hazal Haytural, et al.
Pageof 2